Patient-Reported Outcomes, Tumor Markers, and Survival Outcomes in Advanced GI Cancer

por Jarnagin, Joy X., Saraf, Anurag, Baiev, Islam, Chi, Gary, van Seventer, Emily E., Mojtahed, Amirkasra, Allen, Jill N., Clark, Jeffrey W., Blaszkowsky, Lawrence, Giantonio, Bruce J., Weekes, Colin D., Klempner, Samuel J., Franses, Joseph W., Roeland, Eric J., Goyal, Lipika, Siravegna, Giulia, Horick, Nora, Corcoran, Ryan B., Nipp, Ryan D., Parikh, Aparna R.
Publicado 2023

Combined PD-1, BRAF and MEK inhibition in BRAF(V600E) colorectal cancer: a phase 2 trial

por Tian, Jun, Chen, Jonathan H., Chao, Sherry X., Pelka, Karin, Giannakis, Marios, Hess, Julian, Burke, Kelly, Jorgji, Vjola, Sindurakar, Princy, Braverman, Jonathan, Mehta, Arnav, Oka, Tomonori, Huang, Mei, Lieb, David, Spurrell, Maxwell, Allen, Jill N., Abrams, Thomas A., Clark, Jeffrey W., Enzinger, Andrea C., Enzinger, Peter C., Klempner, Samuel J., McCleary, Nadine J., Meyerhardt, Jeffrey A., Ryan, David P., Yurgelun, Matthew B., Kanter, Katie, Van Seventer, Emily E., Baiev, Islam, Chi, Gary, Jarnagin, Joy, Bradford, William B., Wong, Edmond, Michel, Alexa G., Fetter, Isobel J., Siravegna, Giulia, Gemma, Angelo J., Sharpe, Arlene, Demehri, Shadmehr, Leary, Rebecca, Campbell, Catarina D., Yilmaz, Omer, Getz, Gad A., Parikh, Aparna R., Hacohen, Nir, Corcoran, Ryan B.
Publicado 2023